XJXingguo Jing

Xingguo Jing

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xingguo Jing has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Lu Yang

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, YuanjiagangChongqing, China

    4 shared publications
  • Hua Pang

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, YuanjiagangChongqing, China

    3 shared publications
  • Huan Liang

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, YuanjiagangChongqing, China

    3 shared publications
  • Mengdan Li

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, YuanjiagangChongqing, China

    3 shared publications
  • Xiaohui Wang

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, YuanjiagangChongqing, China

    3 shared publications
  • Fu-Xiang Xie

    Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

    1 shared publication

Latest Publications

  • Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma

    by Huan Liang, Weilin Tan, Jie Wang, Mengdan Li, Hua Pang, Xiaohui Wang, Lu Yang, Xingguo Jing

    Purpose This study aims to develop a novel prediction model and risk stratification system that could accurately predict progression-free survival (PFS) in patients with nasopharyngeal carcinoma (NPC). Methods Herein, we included 106 individuals diagnosed with NPC, who underwent 18F-FDG PET/CT scanning before treatment. They were divided into training (n = 76) and validation (n = 30) sets. The prediction model was constructed based on multivariate Cox regression analysis results and its predictive performance was evaluated. Risk factor stratification was performed based on the nomogram scores of each case, and Kaplan–Meier curves were used to evaluate the model’s discriminative ability for high- and low-risk groups. Results Multivariate Cox regression analysis showed that N stage, M stage, SUVmax, MTV, HI, and SIRI were independent factors affecting the prognosis of patients with NPC. In the training set, the model considerably outperformed the TNM stage in predicting PFS (AUCs of 0.931 vs. 0.841, 0.892 vs. 0.785, and 0.892 vs. 0.804 at 1–3 years, respectively). The calibration plots showed good agreement between actual observations and model predictions. The DCA curves further justified the effectiveness of the model in clinical practice. Between high- and low-risk group, 3-year PFS rates were significantly different (high- vs. low-risk group: 62.8% vs. 9.8%, p < 0.001). Adjuvant chemotherapy was also effective for prolonging survival in high-risk patients (p = 0.009). Conclusion Herein, a novel prediction model was successfully developed and validated to improve the accuracy of prognostic prediction for patients with NPC, with the aim of facilitating personalized treatment.


  • Open Access

    Predicting epithelial ovarian cancer prognosis: correlation of posttreatment 18F-fluorodeoxyglucose positron emission tomography-computed tomography metabolic parameters, serum carbohydrate antigen, and human epididymis protein levels with overall survival

    by Lu Yang, Mengdan Li, Huan Liang, Xiaohui Wang, Lili Guan, Xingguo Jing

    Background: Identifying reliable prognostic indicators can aid in improving patient care. The aim of this study was to establish the association of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) whole-body metabolic parameters, serum carbohydrate antigen 125 (CA125), and human epididymis protein 4 (HE4) with overall survival (OS) in patients with epithelial ovarian cancer (EOC) after surgery combined with platinum-based chemotherapy. Methods: From May 2014 to May 2019, a total of 79 patients with EOC who underwent posttreatment 18F-FDG PET/CT in the First Affiliated Hospital of Chongqing Medical University were included. Clinical data and laboratory indicators were obtained. The whole-body maximum standardized uptake value (WBSUVmax), whole-body metabolic tumor volume (WBMTV), and whole-body total lesion glycolysis (WBTLG) were measured and calculated on 18F-FDG PET/CT. The follow-up was conducted until February 2023, and the endpoint was death from any cause. Pearson correlation analysis, Kaplan-Meier, and Cox proportional regression were used in this study. Results: The PET-positive (PET-P) patients had significantly decreased OS based on either Kaplan-Meier survival analysis (PConclusions: Post-PET/CT treatment strategy, WBMTV, and WBTLG demonstrated significant prognostic utility in predicting posttreatment OS in patients with EOC. Patients who tested positive for both tumor markers CA125 and HE4 and had a positive PET scan demonstrated a significantly poorer prognosis in terms of posttreatment OS.


  • Open Access

    Prognostic utility of 99mTc-MIBI single photon emission computerized tomography myocardial perfusion imaging in patients with ischemia and non-obstructive coronary artery disease

    by Xiao-Hui Wang, Meng-Dan Li, Fu-Xiang Xie, Huan Liang, Lu Yang, Xiao-Fei Wei, Hua Pang, Zheng-Jie Wang, Xing-Guo Jing&Ast

    Objective: The aim of our study was to evaluate the prognostic value of gated SPECT MPI in non-obstructed coronary arteries (INOCA) patients, sought to stratify patients more accurately and thus derive more reliable prognostic information.Materials and methods: In total, 167 patients with INOCA were enrolled. The patients were divided into two groups according to their SSS. Patients were followed-up regularly in terms of major adverse cardiovascular event (MACE), including cardiac death, nonfatal myocardial infarction, stroke, re-hospitalization with angina pectoris, and recurrent angina pectoris. Kaplan-Meier curves and Cox's proportional hazards models were used to analyze survival and identify predictive factors.Results: Adverse cardiac events occurred in 33 cases (19.8%). The rate of MACE was higher in the summed stress score (SSS) ≥4 group than in the SSS 0–3 group (30.1% vs. 9.5%, respectively, P = 0.001) and MACE-free survival was lower (annual MACE-free rates of 87.5% vs. 96.2%, respectively, P = 0.003). Event-free survival was consistently higher in patients with normal arteries than in those with non-obstructive coronary artery disease (annual MACE-free rates of 96.1% and 88.4%, P = 0.035). When the SSS and the CAG results were combined, patients with normal coronary arteries (SSS 0–3) had the best prognosis and those with non-obstructive coronary artery stenosis (SSS ≥ 4) had the worst. However, the early prognosis of patients with non-obstructive coronary artery disease and SSS of 0–3 was comparable to that of patients with normal coronary arteries and SSS ≥ 4 (annual MACE-free rates of 100%, 94.6%, 93.1%, and 78.2%, respectively). Multivariate Cox's regression indicated that the SSS [hazard ratio (HR) = 1.126, 95% confidence interval (CI) 1.042–1.217, P = 0.003] and non-obstructive coronary artery disease (HR = 2.559, 95% CI 1.249–5.246, P = 0.01) were predictors of adverse cardiac events.Conclusion: SPECT MPI data were prognostic for INOCA patients, thus identifying groups at high risk. The long-term predictive efficacy of such data exceeded that of CAG data. A combination of the two measures more accurately stratified INOCA patients in terms of risk.


  • Open Access

    Value of 18F-FCH PET/CT for Diagnosing and Differentiating Hyperplasia From Adenoma

    by Mengdan Li, Shuang Liu, Xiaohui Wang, Lu Yang, Zhengjie Wang, Lu Xu, Xingguo Jing, Hua Pang

    Objective:Due to the different surgical approaches for hyperplasia and adenoma in primary hyperparathyroidism, accurate preoperative diagnosis and identification are key factors affecting the surgery.18F-FCH PET/CT imaging is one of the effective methods for preoperative localization of hyperparathyroidism and can quantify parathyroid function by metabolic parameters. Therefore, the aim of this study was to analyze the diagnostic and differential value of18F-FCH PET/CT for hyperplasia and adenoma.Methods:This was a retrospective analysis of data related to 63 patients undergoing18F-FCH PET/CT at the First Hospital of Chongqing Medical University between December 2017 and December 2022. All procedures were completed, and postoperative pathological data were available for all patients. Comparison of laboratory parameters such as PTH and serum calcium between different patients to assess whether hyperplasia and adenoma can be distinguished based on laboratory indices, and analysis of PET/CT diagnosis and differences in metabolic parameters based on individual parathyroid lesions.The Mann–Whitney U test and binary logistic stepwise regression analysis were also used for univariate and multivariate analyses of information related to hyperplasia and adenomas, and the indicators found to be significant on multivariate analysis were used to determine cutoff values by receiver operating characteristic analysis.Results:A total of 75 parathyroid lesions were ultimately removed postoperatively in 63 patients, including 41 hyperplasia and 34 adenoma, and multiple lesions were present simultaneously in 9 patients. There were no significant differences in laboratory parameters between the different patient groups (P > 0.05). Based on the analysis of individual lesions, the sensitivity of PET/CT for the diagnosis of hyperplasia was 68.29% and that of adenoma was 97.06%. The sensitivity of PET/CT for adenoma was significantly higher than that of hyperplasia, and the size of the lesion may be the main factor affecting the sensitivity; in terms of differences in metabolic parameters, dual-phase SUVmax, MTV and TLG were significant in univariate analysis, and multivariate analysis showed the delayed TLG (cut-off value of 6.421) was a more reliable index for differentiating hyperplasia from adenoma (P=0.002).Conclusion:The diagnostic value of18F-FCH PET/CT for adenoma is higher than that of hyperplasia. Delayed TLG can differentiate hyperplasia from adenoma at the imaging level and help in the selection of clinical treatment options.